Casi Pharmaceuticals, INC. 6-K Filing
Ticker: CASIF · Form: 6-K · Filed: Nov 19, 2025 · CIK: 1962738
Sentiment: neutral
Filing Stats: 234 words · 1 min read · ~1 pages · Grade level 11 · Accepted 2025-11-19 09:15:18
Filing Documents
- tm2531587d1_6k.htm (6-K) — 11KB
- tm2531587d1_ex99-1.htm (EX-99.1) — 17KB
- tm2531587d1_ex99-1img01.jpg (GRAPHIC) — 6KB
- 0001104659-25-113974.txt ( ) — 38KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CASI Pharmaceuticals, Inc. By: /s/ David Cory Name: David Cory Title: CEO Date: November 19, 2025